Christina Y. Weng: Power List Perspectives

1. Dr. Weng highlights progress in retina treatments.
2. First treatment for macular telangiectasia type 2 approved.
3. Gene therapy options are expanding.
4. Home OCT system cleared for patient use.
5. Future will focus on personalized medicine.
6. Imaging biomarkers and genetic testing will guide treatment.
7. Ongoing clinical trials are crucial for advancing care. 8. AI technologies may customize patient treatment schedules.